These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 16926745

  • 1. Heartburn severity does not predict disease severity in patients with erosive esophagitis.
    Fennerty MB, Johnson DA.
    MedGenMed; 2006 Apr 06; 8(2):6. PubMed ID: 16926745
    [Abstract] [Full Text] [Related]

  • 2. Obesity does not affect treatment outcomes with proton pump inhibitors.
    Sharma P, Vakil N, Monyak JT, Silberg DG.
    J Clin Gastroenterol; 2013 Sep 06; 47(8):672-7. PubMed ID: 23442835
    [Abstract] [Full Text] [Related]

  • 3. Healing of erosive esophagitis and improvement of symptoms of gastroesophageal reflux disease after esomeprazole treatment in children 12 to 36 months old.
    Tolia V, Gilger MA, Barker PN, Illueca M.
    J Pediatr Gastroenterol Nutr; 2010 Nov 06; 51(5):593-8. PubMed ID: 20706150
    [Abstract] [Full Text] [Related]

  • 4. Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis.
    Castell DO, Kahrilas PJ, Richter JE, Vakil NB, Johnson DA, Zuckerman S, Skammer W, Levine JG.
    Am J Gastroenterol; 2002 Mar 06; 97(3):575-83. PubMed ID: 11922549
    [Abstract] [Full Text] [Related]

  • 5. Predictors of heartburn resolution and erosive esophagitis in patients with GERD.
    Orlando RC, Monyak JT, Silberg DG.
    Curr Med Res Opin; 2009 Sep 06; 25(9):2091-102. PubMed ID: 19601705
    [Abstract] [Full Text] [Related]

  • 6. Association of body mass index with heartburn, regurgitation and esophagitis: results of the Progression of Gastroesophageal Reflux Disease study.
    Nocon M, Labenz J, Jaspersen D, Meyer-Sabellek W, Stolte M, Lind T, Malfertheiner P, Willich SN.
    J Gastroenterol Hepatol; 2007 Nov 06; 22(11):1728-31. PubMed ID: 17914941
    [Abstract] [Full Text] [Related]

  • 7. [Proton pump inhibitors according to need. Always for heartburn].
    Labenz J.
    MMW Fortschr Med; 2002 Jun 06; 144(23):34-7. PubMed ID: 12119901
    [Abstract] [Full Text] [Related]

  • 8. Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies.
    Laine L, Sugg J.
    Am J Gastroenterol; 2002 Dec 06; 97(12):2992-7. PubMed ID: 12492181
    [Abstract] [Full Text] [Related]

  • 9. Maintenance of healed erosive esophagitis: a randomized six-month comparison of esomeprazole twenty milligrams with lansoprazole fifteen milligrams.
    Devault KR, Johanson JF, Johnson DA, Liu S, Sostek MB.
    Clin Gastroenterol Hepatol; 2006 Jul 06; 4(7):852-9. PubMed ID: 16682260
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of esomeprazole 40 mg vs. lansoprazole 30 mg for healing moderate to severe erosive oesophagitis.
    Fennerty MB, Johanson JF, Hwang C, Sostek M.
    Aliment Pharmacol Ther; 2005 Feb 15; 21(4):455-63. PubMed ID: 15709997
    [Abstract] [Full Text] [Related]

  • 11. Symptom response and healing of erosive esophagitis with proton-pump inhibitors in patients with Helicobacter pylori infection.
    Vakil NB, Traxler BM, Levine D.
    Am J Gastroenterol; 2004 Aug 15; 99(8):1437-41. PubMed ID: 15307856
    [Abstract] [Full Text] [Related]

  • 12. Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis - a post hoc analysis of 5796 patients.
    Bytzer P, van Zanten SV, Mattsson H, Wernersson B.
    Aliment Pharmacol Ther; 2012 Oct 15; 36(7):635-43. PubMed ID: 22860764
    [Abstract] [Full Text] [Related]

  • 13. Gastroesophageal reflux disease symptoms on antisecretory therapy: acid, non-acid, or no GERD.
    Katz PO.
    Rev Gastroenterol Disord; 2006 Oct 15; 6(3):136-45. PubMed ID: 16957654
    [Abstract] [Full Text] [Related]

  • 14. Healing of Erosive Esophagitis and Improvement of Symptoms of Gastroesophageal Reflux Disease After Esomeprazole Treatment in Children 12 to 36 Months Old.
    Tolia V, Gilger MA, Barker PN, Illueca M.
    J Pediatr Gastroenterol Nutr; 2015 Jul 15; 60 Suppl 1():S31-6. PubMed ID: 26121348
    [Abstract] [Full Text] [Related]

  • 15. Predictors of treatment response in patients with non-erosive reflux disease.
    Talley NJ, Armstrong D, Junghard O, Wiklund I.
    Aliment Pharmacol Ther; 2006 Jul 15; 24(2):371-6. PubMed ID: 16842464
    [Abstract] [Full Text] [Related]

  • 16. Distinguishing the impact of dexlansoprazole on heartburn vs. regurgitation in patients with gastro-oesophageal reflux disease.
    Peura DA, Pilmer B, Hunt B, Mody R, Perez MC.
    Aliment Pharmacol Ther; 2013 Nov 15; 38(10):1303-11. PubMed ID: 24118079
    [Abstract] [Full Text] [Related]

  • 17. Healing of Erosive Esophagitis and Improvement of Symptoms of Gastroesophageal Reflux Disease After Esomeprazole Treatment in Children 12 to 36 Months Old.
    Tolia V, Gilger MA, Barker PN, Illueca M.
    J Pediatr Gastroenterol Nutr; 2015 Jul 15; 60 Suppl 1():S31-6. PubMed ID: 26422096
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparing lansoprazole and omeprazole in onset of heartburn relief: results of a randomized, controlled trial in erosive esophagitis patients.
    Richter JE, Kahrilas PJ, Sontag SJ, Kovacs TO, Huang B, Pencyla JL.
    Am J Gastroenterol; 2001 Nov 15; 96(11):3089-98. PubMed ID: 11721754
    [Abstract] [Full Text] [Related]

  • 20. Look--but also listen! ReQuest: an essay on a new validated scale to assess the outcome of GERD treatment.
    Bardhan KD, Berghöfer P.
    Digestion; 2007 Nov 15; 75 Suppl 1():87-100. PubMed ID: 17489037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.